Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Leukemia × pevonedistat × Clear all

Phase

Status

Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 3 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Mesothelioma 1 Leukemia 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 48 fludarabine phosphate 36 Methotrexate 26 Cytarabine 24 fludarabine 23 Whole-Body Irradiation 23 Rituximab 19 Cyclosporine 19 Antilymphocyte Serum 18 Peripheral Blood Stem Cell Transplantation 17 Filgrastim 17 Busulfan 17 Mycophenolic Acid 16 Tacrolimus 15 Azacitidine 15 Alemtuzumab 15 Radiotherapy 13 Melphalan 13 Imatinib Mesylate 13 Etoposide 13 Vincristine 11 Methylprednisolone 11 Cord Blood Stem Cell Transplantation 11 Dexamethasone 10 Granulocyte Colony-Stimulating Factor 8 Clofarabine 8 venetoclax 7 thymoglobulin 7 sargramostim 7 nilotinib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04172844 2024-06-04

PAVE

Medical College of Wisconsin

Phase 1 Terminated

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡